Rational design of PROTACs empowered by deep generative modeling: current advances and future perspectives.
Deep generative modeling (DGM) represents a transformative paradigm in proteolysis-targeting chimera (PROTAC) discovery, transitioning the field from empirical trial-and-error and computer-aided drug design (CADD) toward data-driven, autonomous candidate generation. PROTAC design presents a high-dimensional systems eng...